youtube_live
Q3 2026 earnings • released • EPS beat +7,77% • Revenue beat +2,93%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
158,79 $
arrow_upward
+5,25%(+7,92) 1D
158,79 $
0,00% (0,00)
bedtimeAfter hours
Closed: 9 қар., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
152,78 $
High
162,96 $
Low
149,40 $
Mkt. cap
21,31 млрд
Avg. vol.
2,00 млн
Volume
3,10 млн
52-wk high
191,05 $
52-wk low
74,55 $
EPS
-3,68 $
Beta
1,67
Shares outstanding
135,29 млн
No. of employees
2 мың
Open
152,78 $
High
162,96 $
Low
149,40 $
Mkt. cap
21,31 млрд
Avg. vol.
2,00 млн
Volume
3,10 млн
52-wk high
191,05 $
52-wk low
74,55 $
EPS
-3,68 $
Beta
1,67
Shares outstanding
135,29 млн
No. of employees
2 мың
News stories
From web sources and news partners
Yahoo Finance
·
54 минут бұрын
Guardant Health to Participate in Upcoming Investor Conferences
Yahoo Finance
·
12 сағат бұрын
GH Q3 2026 deep dive: new product launches and coverage wins drive growth, but market cautious on profitability
GuruFocus
·
3 күн бұрын
Guardant Health Stocks Fall 9.49% as Cash Burn Outlook Rises Des
Yahoo Finance
·
3 күн бұрын
Guardant Health, Inc. Q3 2026 Earnings Call Summary
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 мың
Founded2012
HeadquartersПало Альто, Калифорния, Америка Құрама Штаттары
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com